• Karyopharm Therapeutics' (KPTI) "Buy" Rating Reiterated at HC Wainwright

    Source: Buzz FX / 15 Jan 2025 06:26:16   America/Chicago


    Karyopharm Therapeutics' (KPTI) "Buy" Rating Reiterated at HC Wainwright Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Karyopharm Therapeutics ( NASDAQ:KPTI - Get Free Report ) 's stock had its "buy" rating reiterat
    Read more...
Share on,